These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6270355)

  • 21. Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine.
    Sefton BM; Hunter T; Raschke WC
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1552-6. PubMed ID: 6262813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts.
    Rohrschneider LR; Najita LM
    J Virol; 1984 Aug; 51(2):547-52. PubMed ID: 6086963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some lymphoid cell lines transformed by Abelson murine leukemia virus lack a major 36,000-dalton tyrosine protein kinase substrate.
    Sefton BM; Hunter T; Cooper JA
    Mol Cell Biol; 1983 Jan; 3(1):56-63. PubMed ID: 6298608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
    Parmar K; Rosenberg N
    J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
    Wang JY; Baltimore D
    Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.
    Konopka JB; Davis RL; Watanabe SM; Ponticelli AS; Schiff-Maker L; Rosenberg N; Witte ON
    J Virol; 1984 Jul; 51(1):223-32. PubMed ID: 6610061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abelson murine leukemia virus variants with increased oncogenic potential.
    Murtagh K; Skladany G; Hoag J; Rosenberg N
    J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
    Watanabe SM; Witte ON
    J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis.
    Engelman A; Rosenberg N
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8021-5. PubMed ID: 2825174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
    Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
    J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression of Abelson murine leukemia virus.
    Witte ON; Rosenberg N; Baltimore D
    Prog Clin Biol Res; 1980; 41():757-64. PubMed ID: 6256775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.
    Schiff-Maker L; Burns MC; Konopka JB; Clark S; Witte ON; Rosenberg N
    J Virol; 1986 Mar; 57(3):1182-6. PubMed ID: 3005619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abelson murine leukemia virus: characterization of a polyprotein containing phosphorylated component(s) encoded by newly acquired sequences.
    Stephenson JR; Reynolds FH; van de Ven WJ
    Arch Geschwulstforsch; 1980; 50(3):204-13. PubMed ID: 6254463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lethal effect of the Abelson murine leukemia virus transforming gene product.
    Ziegler SF; Whitlock CA; Goff SP; Gifford A; Witte ON
    Cell; 1981 Dec; 27(3 Pt 2):477-86. PubMed ID: 6101202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of the Abelson murine leukemia virus protein in a detergent-insoluble subcellular matrix: architecture of the protein.
    Boss MA; Dreyfuss G; Baltimore D
    J Virol; 1981 Nov; 40(2):472-81. PubMed ID: 6172595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
    Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
    Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.